These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 17582439
21. Trafficking and differentiation of mesenchymal stem cells. Liu ZJ, Zhuge Y, Velazquez OC. J Cell Biochem; 2009 Apr 15; 106(6):984-91. PubMed ID: 19229871 [Abstract] [Full Text] [Related]
22. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Sadan O, Melamed E, Offen D. Expert Opin Biol Ther; 2009 Dec 15; 9(12):1487-97. PubMed ID: 19821796 [Abstract] [Full Text] [Related]
23. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, Roh W, Hwang SJ, Ko HJ, Huh YM, Kim HT, Kim SH. Brain Res; 2008 Sep 10; 1229():233-48. PubMed ID: 18634757 [Abstract] [Full Text] [Related]
24. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY, STARTING collaborators. Stem Cells; 2010 Jun 10; 28(6):1099-106. PubMed ID: 20506226 [Abstract] [Full Text] [Related]
25. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study. Kim HY, Kim H, Oh KW, Oh SI, Koh SH, Baik W, Noh MY, Kim KS, Kim SH. Stem Cells; 2014 Oct 10; 32(10):2724-31. PubMed ID: 24966156 [Abstract] [Full Text] [Related]
26. Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells. Rooney GE, McMahon SS, Ritter T, Garcia Y, Moran C, Madigan NN, Flügel A, Dockery P, O'Brien T, Howard L, Windebank AJ, Barry FP. Tissue Eng Part A; 2009 Oct 10; 15(10):3049-59. PubMed ID: 19335061 [Abstract] [Full Text] [Related]
27. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montagna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F. Cancer Res; 2007 Oct 01; 67(19):9142-9. PubMed ID: 17909019 [Abstract] [Full Text] [Related]
28. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Chen MY, Lie PC, Li ZL, Wei X. Exp Hematol; 2009 May 01; 37(5):629-40. PubMed ID: 19375653 [Abstract] [Full Text] [Related]
29. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H. Biol Blood Marrow Transplant; 2007 Dec 01; 13(12):1477-86. PubMed ID: 18022578 [Abstract] [Full Text] [Related]
30. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Kastrinaki MC, Sidiropoulos P, Roche S, Ringe J, Lehmann S, Kritikos H, Vlahava VM, Delorme B, Eliopoulos GD, Jorgensen C, Charbord P, Häupl T, Boumpas DT, Papadaki HA. Ann Rheum Dis; 2008 Jun 01; 67(6):741-9. PubMed ID: 17921184 [Abstract] [Full Text] [Related]
31. Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals. Tichon A, Gowda BK, Slavin S, Gazit A, Priel E. Cytotherapy; 2009 Jun 01; 11(7):837-48. PubMed ID: 19903097 [Abstract] [Full Text] [Related]
32. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Huang H, Chen L, Xi H, Wang H, Zhang J, Zhang F, Liu Y. Clin Transplant; 2008 Jun 01; 22(6):710-8. PubMed ID: 18673377 [Abstract] [Full Text] [Related]
33. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Zheng ZH, Li XY, Ding J, Jia JF, Zhu P. Rheumatology (Oxford); 2008 Jan 01; 47(1):22-30. PubMed ID: 18077486 [Abstract] [Full Text] [Related]
34. Locally applied osteogenic predifferentiated progenitor cells are more effective than undifferentiated mesenchymal stem cells in the treatment of delayed bone healing. Peters A, Toben D, Lienau J, Schell H, Bail HJ, Matziolis G, Duda GN, Kaspar K. Tissue Eng Part A; 2009 Oct 01; 15(10):2947-54. PubMed ID: 19302033 [Abstract] [Full Text] [Related]
35. Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility. Martínez HR, Molina-Lopez JF, González-Garza MT, Moreno-Cuevas JE, Caro-Osorio E, Gil-Valadez A, Gutierrez-Jimenez E, Zazueta-Fierro OE, Meza JA, Couret-Alcaraz P, Hernandez-Torre M. Cell Transplant; 2012 Oct 01; 21(9):1899-907. PubMed ID: 23356668 [Abstract] [Full Text] [Related]
37. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C, Watt SM. Vox Sang; 2008 Aug 01; 95(2):137-48. PubMed ID: 18557828 [Abstract] [Full Text] [Related]
39. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. Chen L, Huang H, Zhang J, Zhang F, Liu Y, Xi H, Wang H, Gu Z, Song Y, Li Y, Tan K. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Sep 01; 21(9):961-6. PubMed ID: 17933231 [Abstract] [Full Text] [Related]